Clinical trial
Impact of rhCu/Zn SOD on Inflammation-Induced Impairment of Vascular Reactivity
NCT00264186 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of rhCu/Zn SOD on Inflammation-Induced Impairment of Vascular Reactivity
- Lead sponsor
- Medical University of Vienna
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 30, 2005
- Completion date
- Not reported
- Enrollment
- 43
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.